| An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions A Arvey, I Tempera, K Tsai, HS Chen, N Tikhmyanova, M Klichinsky, ... Cell host & microbe 12 (2), 233-245, 2012 | 273 | 2012 |
| Epigenetic regulation of EBV persistence and oncogenesis I Tempera, PM Lieberman Seminars in cancer biology 26, 22-29, 2014 | 145 | 2014 |
| EBV latency types adopt alternative chromatin conformations I Tempera, M Klichinsky, PM Lieberman PLoS pathogens 7 (7), e1002180, 2011 | 138 | 2011 |
| CTCF prevents the epigenetic drift of EBV latency promoter Qp I Tempera, A Wiedmer, J Dheekollu, PM Lieberman PLoS pathogens 6 (8), e1001048, 2010 | 132 | 2010 |
| Interferon-γ signaling in melanocytes and melanoma cells regulates expression of CTLA-4 X Mo, H Zhang, S Preston, K Martin, B Zhou, N Vadalia, AM Gamero, ... Cancer research 78 (2), 436-450, 2018 | 111 | 2018 |
| PARP-1 modulates amyloid beta peptide-induced neuronal damage S Martire, A Fuso, D Rotili, I Tempera, C Giordano, I De Zottis, A Muzi, ... PLoS One 8 (9), e72169, 2013 | 94 | 2013 |
| Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival I Tempera, A De Leo, AV Kossenkov, M Cesaroni, H Song, N Dawany, ... Journal of virology 90 (1), 345-355, 2016 | 79 | 2016 |
| Chromatin organization of gammaherpesvirus latent genomes I Tempera, PM Lieberman Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1799 (3-4 …, 2010 | 75 | 2010 |
| CTCF binding site sequence differences are associated with unique regulatory and functional trends during embryonic stem cell differentiation RN Plasschaert, S Vigneau, I Tempera, R Gupta, J Maksimoska, L Everett, ... Nucleic acids research 42 (2), 774-789, 2013 | 73 | 2013 |
| Regulation of Epstein-Barr virus OriP replication by poly (ADP-ribose) polymerase 1 I Tempera, Z Deng, C Atanasiu, CJ Chen, M D'Erme, PM Lieberman Journal of virology 84 (10), 4988-4997, 2010 | 72 | 2010 |
| Epigenetic deregulation of the LMP1/LMP2 locus of Epstein-Barr virus by mutation of a single CTCF-cohesin binding site HS Chen, KA Martin, F Lu, LN Lupey, JM Mueller, PM Lieberman, ... Journal of virology 88 (3), 1703-1713, 2014 | 68 | 2014 |
| Interpreting the Epstein-Barr Virus (EBV) epigenome using high-throughput data A Arvey, I Tempera, PM Lieberman Viruses 5 (4), 1042-1054, 2013 | 59 | 2013 |
| PARP1 stabilizes CTCF binding and chromatin structure to maintain Epstein-Barr virus latency type LN Lupey-Green, LB Caruso, J Madzo, KA Martin, Y Tan, M Hulse, ... Journal of virology 92 (18), 10.1128/jvi. 00755-18, 2018 | 49 | 2018 |
| HIV-1 Vpr disrupts mitochondria axonal transport and accelerates neuronal aging Y Wang, M Santerre, I Tempera, K Martin, R Mukerjee, BE Sawaya Neuropharmacology 117, 364-375, 2017 | 48 | 2017 |
| Epstein-Barr virus oncoprotein LMP1 mediates epigenetic changes in host gene expression through PARP1 KA Martin, LN Lupey, I Tempera Journal of virology 90 (19), 8520-8530, 2016 | 48 | 2016 |
| PARP1 restricts Epstein Barr Virus lytic reactivation by binding the BZLF1 promoter LN Lupey-Green, SA Moquin, KA Martin, SM McDevitt, M Hulse, ... Virology 507, 220-230, 2017 | 44 | 2017 |
| Global transcriptome analysis reveals that poly (ADP-ribose) polymerase 1 regulates gene expression through EZH2 KA Martin, M Cesaroni, MF Denny, LN Lupey, I Tempera Molecular and cellular biology, 2015 | 44 | 2015 |
| Oncogenic viruses as entropic drivers of cancer evolution I Tempera, PM Lieberman Frontiers in virology 1, 753366, 2021 | 43 | 2021 |
| Epstein-Barr virus-encoded latent membrane protein 1 and B-cell growth transformation induce lipogenesis through fatty acid synthase M Hulse, SM Johnson, S Boyle, LB Caruso, I Tempera Journal of virology 95 (4), 10.1128/jvi. 01857-20, 2021 | 41 | 2021 |
| Poly (ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 M Hulse, LB Caruso, J Madzo, Y Tan, S Johnson, I Tempera PLoS Pathogens 14 (11), e1007394, 2018 | 41 | 2018 |
Paul M. LiebermanThe Wistar InstituteGeverifieerd e-mailadres voor wistar.org
